Bio‑Rad Laboratories Inc – Company Overview and Recent Market Activity
Company Profile
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Exchange: New York Stock Exchange (NYSE)
- Currency: USD
- Market Capitalization: $6.16 billion
- Price‑to‑Earnings Ratio: 29.78
Bio‑Rad Laboratories, Inc. manufactures and distributes products for life‑science research, clinical diagnostics, and analytical instrumentation. The company’s offerings enable separation, analysis, identification, and purification of complex chemical and biological materials. Its official website is www.bio‑rad.com.
Recent Stock Performance (as of 2025‑09‑16)
- Closing price: $280.29
- 52‑week high: $387.99 (2024‑11‑05)
- 52‑week low: $211.43 (2025‑06‑02)
Recent News Summary
No financial news items directly referencing Bio‑Rad Laboratories were included in the provided input. Consequently, no new corporate announcements, earnings releases, or market‑impact events are reported for the company as of the date of this article.